Core Viewpoint - The development of a high-flow oxygen nebulization device by a county hospital has been recognized as a key project in the province, highlighting the importance of clinical needs driving innovation in medical device development [1][2]. Group 1: Project Recognition and Impact - The high-flow nebulization device project aims to enhance the precision and safety of oxygen therapy and nebulization treatment for critically ill patients, marking a significant achievement for Zaozhuang City in creating a closed loop of "clinical demand - research innovation - industrial transformation" [1]. - Since 2025, Zaozhuang's market supervision administration has focused on high-quality development in the pharmaceutical industry, using clinical transformation of medical devices as a breakthrough point, resulting in 13 clinical innovation projects being included in the reserve, with two projects recognized as provincial key projects [1][2]. Group 2: Innovation and Collaboration Mechanisms - The market supervision administration has established direct dialogue mechanisms with clinical department heads and technical experts to identify market potential and feasible innovations, exemplified by the high-flow nebulization device project [2]. - To address the information asymmetry and collaboration challenges among medical, research, and enterprise sectors, the administration plays a bridging role, facilitating regular interactions between clinical experts, researchers, and engineers to match technical needs with engineering solutions [2]. Group 3: Support and Guidance for Development - The market supervision administration seeks breakthroughs in innovation service models by providing early intervention, tailored strategies, and comprehensive guidance throughout the product development process, significantly improving application quality and approval rates [3]. - The administration coordinates various innovation policies and resolves challenges faced by enterprises in testing, assessment, and licensing, thereby optimizing the product market entry environment [3].